Your browser doesn't support javascript.
loading
Early hydroxyurea use is neuroprotective in children with sickle cell anemia.
Karkoska, Kristine; Pfeiffer, Amanda; Beebe, Dean W; Quinn, Charles T; Niss, Omar; McGann, Patrick T.
Afiliação
  • Karkoska K; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Pfeiffer A; Division of Hematology, Cancer & Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Beebe DW; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Quinn CT; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Niss O; Division of Hematology, Cancer & Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • McGann PT; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Am J Hematol ; 97(10): E368-E370, 2022 10.
Article em En | MEDLINE | ID: mdl-35836401
Children with sickle cell disease (SCD) who began hydroyxurea before age five years scored no differently on a measure of cognitive funciton than age, sex, and race-matched unaffected peers.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidroxiureia / Anemia Falciforme Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidroxiureia / Anemia Falciforme Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article